Equity
€655,747 ▲ 7.7%
DEMETER has made a profit without a break since 2015.
DEMETER
Lifetime
20 annual accounts with figures on one time axis, 28 filings since 1998peak €213,312 (2024)
€99,933▼ 53.2%
lowest -€31,011 (2014)
€46,729▼ 66.4%
peak €655,747 (2025)
€655,747▲ 7.7%
€34,212▼ 67.7%
peak 0.4 FTE (2013)
-not published
Board1 name since 1998
1 director
Owners
Documentsfilings and deeds
05-08-20265 days late
2025micro format
Gross margin from €213,312 to €99,933Result from €139,036 to €46,729Debts from €105,914 to €34,212
Key points
from the 2025 annual accountsResult
€46,729 ▼ 66.4%
The result fell in 2025 from €139,036 to €46,729.
Turnover
≈ €220,000 estimated
The micro format states no turnover.
Liquidity
15.95 was 5.72 in 2024
Short-term debts fell from €98,719 to €34,212.
Filings
28 annual accounts since 1998
Eight of the last ten came late. The 2017 accounts came latest: 48 days after the end of the period.
Position in the sector
95.0%
Higher solvency than 91% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as DEMETER has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for DEMETER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0462370492
Appointment: (statutory director)
holds all the shares · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 12-04-2023 · Gazette deed
Incorporation
published on 20-01-1998 · Gazette deed
First establishment
Winston Churchilllaan 28, Uccle
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DEMETER Uccle | €689,959 | €99,933 | 95.0% | - |
| DOKTER KATTY BOURGOIGNIE Ostend | €710,655 | €97,247 | 97.8% | - |
| ORTHODES Péruwelz | €618,350 | €94,535 | 81.2% | - |
| DOKTER WALTER PENDERS Lebbeke | €659,165 | €89,580 | 87.5% | 0.3 |
| DOKTER RITA VAN GINDERDEUREN Diest | €647,724 | €93,678 | 94.4% | - |
| CABINET MEDICAL DU DOCTEUR WALRAVENS Thuin | €618,577 | €98,739 | 53.8% | - |
| DR. JANKIE SASKIA Malle | €699,699 | €100,338 | 81.6% | - |
These companies have the same main activity as DEMETER: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €618,000 and €711,000, founded between 1996 and 2002.
Official details
Source: KBO- Status
- Active since 08-01-1998Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330Health institutions and services · annual accounts 2025
- Establishment unit
- 2.229.115.0321180 Uccle, since 07-01-1998
- Financial year end
- 31 December
- Peppol
- Reachable since 12-12-2025
Insights on DEMETER
DEMETER files the micro format. That format states no turnover. The gross margin rose from €41,229 in 2006 to €99,933 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DEMETER
- What is the company number of DEMETER?
- The company number of DEMETER is 0462.370.492. The VAT number is the same number with BE in front: BE 0462.370.492.
- Where is DEMETER based?
- The registered office is at Dodonéestraat 83, 1180 Uccle.Company details
- What does DEMETER do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DEMETER?
- DEMETER is a private limited company (BV).
- When was DEMETER founded?
- DEMETER was founded on 08-01-1998.
- Is DEMETER still active?
- Yes, DEMETER is an active enterprise in the KBO register.
- How many employees does DEMETER have?
- DEMETER had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does DEMETER fall under?
- In its 2025 annual accounts, DEMETER states joint committee 330 (Health institutions and services).
- What is the turnover of DEMETER?
- The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €99,933 and 32 comparable companies (NACE 862). It probably lies between €170,000 and €290,000.
- Is DEMETER profitable?
- In financial year 2025, DEMETER made a profit of €46,729.
- Where can I find the annual accounts of DEMETER?
- DEMETER filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DEMETER due?
- DEMETER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.